Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Pharma's 'Brexit Playbook' Might Envision New Regulator Roles

Executive Summary

Britain's life sciences sector is compiling detailed game plan for September talks with the new Conservative government to promote its interests once the UK leaves the EU. All options are being considered – including possible establishment of a best-in-class regulatory agency in Britain.

Advertisement

Related Content

AstraZeneca’s Business Development Head Grady Outlines Strategy Mix
Strong 2Q And Fresh UK Investment Signal Few Brexit Blues at GSK
George Freeman Departure Leaves UK Life Sciences Holding Its Breath
Brain Drain And Recruitment Risks for EMA post UK Brexit Vote
Settle Terms Before Brexit Divorce Is Final, Former EMA Chief Says
UK Pharma Chiefs To Helm Brexit Steering Committee

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS118880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel